This is the first and only treatment that has been shown to quickly and effectively kill fleas and ticks for up to 12 weeks in a single dose. “MSD Animal Health has been granted EU approval for Bravecto, a new chewable tablet treatment for fleas and ticks among dogs.“ MSD Animal Health has been granted European regulatory approval for a convenient new tablet-based treatment for dogs suffering from flea and tick infestations.įollowing a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has granted marketing authorisation to Bravecto, a groundbreaking range of chewable tablets that act as systemic insecticides and acaricides. The data presented on this page does not represent the view of Brave Care and its employees or that of Zippia.īrave Care may also be known as or be related to Brave Care, Brave Care Inc and Brave Care, Inc.MSD Animal Health receives EU approval for Bravecto 19 February 2014 Animal Health Supplier News None of the information on this page has been provided or approved by Brave Care. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. The employee data is based on information from people who have self-reported their past or current employments at Brave Care. Zippia gives an in-depth look into the details of Brave Care, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Brave Care.

Brave health salary